MedTrace Logo

Genetic Basis of Rosacea

NCT02787616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2019-09-26

No results posted yet for this study

Summary

Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. The exact pathogenesis of papulopustular rosacea is not well understood and current methods to treat this disease are often unsatisfactory. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigators hope to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.

Conditions

  • Rosacea

Interventions

GENETIC

buccal swab

cheek swab for DNA sampling

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-13
Primary Completion
2018-11-16
Completion
2018-11-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02787616 on ClinicalTrials.gov